Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

Launched by MAYO CLINIC · Mar 12, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on improving a type of medical imaging called MR angiography and MR perfusion imaging, which are used to get detailed pictures of blood vessels and surrounding tissues in patients with prostate cancer. The goal is to see if these enhanced imaging techniques provide clearer and more accurate information than current methods, which can help doctors make better treatment decisions.

The trial is open to adults aged 65 to 74, regardless of gender. However, certain individuals may not be eligible to participate, especially those with specific medical devices like pacemakers or those who might feel anxious in an MRI machine, as well as people who have had previous surgeries that could affect the imaging process. Participants in the study can expect to undergo advanced imaging procedures that will help researchers understand how well these new techniques work. Overall, this trial aims to improve the way prostate cancer is diagnosed and monitored, potentially benefiting many patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults
• Exclusion Criteria:
• • Standard exclusion criteria for clinical MRI; e.g. cardiac pacemaker, claustrophobia, an implanted device that has been determined to be MR conditional at 1.5T but not at 3T, anticipated considerable susceptibility artifact from hip prosthesis, etc.